Aptamers: A novel approach to intervention studies and the development of novel therapeutic approaches;Aptamere: Ein neuer anzatz fur interventionsstudien und zur entwicklung zukunftiger therapieansatze

Medizinische Klinik

Volumn 94, Issue 4, 1999, Pages 219-223

  Ostendorf, Tammo ^b   Floege, Jürgen ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Antagonist; Glomerulonephritis; Mesangial cells; Oligonucleotid; PDGF

Indexed keywords

APTAMER; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; DNA; OLIGONUCLEOTIDE; RNA;

BINDING AFFINITY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; GLOMERULONEPHRITIS; LIGAND BINDING; REVIEW; CHEMISTRY; HUMAN;

DNA; HUMANS; OLIGONUCLEOTIDES; RNA;

EID: 0033560314     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03044858     Document Type: Review

References (14)

1. Eaton BE. The joys of in vitro selection: chemically dressing oligonucleotides to satiate protein targets. Curr Opin Chem Biol 1997;1:10-6.
2. Eaton BE, Gold L, Hicke BJ, et al. Post-SELEX combinatorial optimization of aptamers. Bioorg Med Chem 1997;5:1087-96.
3. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990;346: 818-22.
4. Famulok M. Molecular recognition of amino acids by RNA-aptamers: an L-citrulline binding RNA motif and its evolution into an L-arginine binder. J Am Chem Soc 1994;116:1698-1706.
5. Floege J, Johnson RJ. Multiple roles for platelet-derived growth factor in renal disease. Miner Electrolyte Metab 1995;21:271-82.
6. Floege J, Ostendorf T, Janssen U, et al. A novel approach to specific growth factor inhibition in vivo: antagonism of PDGF in glomerulonephritis by aptamers. Am J Pathol 1999;154:169-79.
7. Gold L, Polisky B, Uhlenbeck O, Yarus M. Diversity of oligonucleotide functions. Annu Rev Biochem 1995; 64:763-97.
8. Griffin LC, Tidmarsh GF, Bock LC, Toole JJ, Leung LL. In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. Blood 1993;81:3271-6.
9. Hicke BJ, Watson SK, Koenig A, et al. DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. J Clin Invest 1996;98:2688-92.
10. Johnson RJ, Raines EW, Floege J, et al. Inhibition of mesangial cell proliferation and matrix expansion in glomeruloneprhritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992;175:1413-6.
11. Nolte A, Klussmann S, Bald R, Erdmann VA, Furste JP. Mirror-design of L-oligonucleotide ligands binding to L-arginine. Nat Biotechnol 1996;14:1116-9.
12. Osborne SE, Ellington AD. Nucleic acid selection and the challenge of combinatorial chemistry. Chem Rev 1997;97:349-70.
13. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990;249:505-10.
14. Yang Q, Goldstein IJ, Mei HY, Engelke DR. DNA ligands that bind tightly and selectively to cellobiose. Proc Natl Acad Sci USA 1998;95:5462-7.